Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)
Christoph Licht(University of Toronto), Peter F. Zipfel(Systems Analytics (United States)), Ina Löschmann(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Stephen J. Perkins(Institute of Structural and Molecular Biology), Michael Kirschfink(Heidelberg University), Bernd Höppe(University of Bonn), Christine Skerka(OncoMed (United States)), Rebecca E. Saunders(The Royal Free Hospital), Mihály Józsi(Eötvös Loránd University), R Waldherr, Stefan Heinen(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI))
Cited by 203
Related Papers
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
The primary hyperoxalurias
|Kidney International|2009|373
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361